6
Feb 2026
New meta-analysis challenges claims of athletic advantage for transgender women
A meta-analysis of 52 studies reveals insights into body composition and fitness in transgender athletes, challenging assumptions about competitive advantage.
6
Feb 2026
A meta-analysis of 52 studies reveals insights into body composition and fitness in transgender athletes, challenging assumptions about competitive advantage.
6
Feb 2026
In 2026 alone, an estimated 4.5 million girls – many under the age of five – are at risk of undergoing female genital mutilation (FGM). Currently, more than 230 million girls and women are living with its lifelong consequences.
6
Feb 2026
The Trump administration's move to give deportation officials access to Medicaid data is putting hospitals and states in a bind as they weigh whether to alert immigrant patients that their personal information, including home addresses, could be used in efforts to remove them from the country.
6
Feb 2026
Social media's portrayal of low testosterone transforms masculinity into a marketable issue, linking health interventions to male identity and performance.
6
Feb 2026
Urgent action is needed as climate change fuels antibiotic resistance in the Western Pacific, threatening health and highlighting socioeconomic vulnerabilities.
6
Feb 2026
Global health burdens associated with plastic systems could double by 2040 without immediate and coordinated action.
5
Feb 2026
For many Americans, a routine surgical procedure serves as their first introduction to opioid pain medication.
5
Feb 2026
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve diagnosis and treatment.
5
Feb 2026
Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, "Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women."
5
Feb 2026
Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more